SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Madrigal Pharmaceuticals, Inc. MDGL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Madrigal Pharmaceuticals, Inc. (MDGL) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ABOS, ACLX, DAWN, ETNB, HEPA, ICPT 等.

MDGL 的市值为 $12.04B, 而同行平均市值为 $2.3B. MDGL 显著大于其平均同行.

同行与相似公司 — MDGL

Acumen Pharmaceuticals, Inc.

$2.68 +6.77% $162.34M

$114.89 +0.02% $6.72B

Day One Biopharmaceuticals, Inc.

$21.46 -0.14% $2.22B

$14.84 0.00% $2.2B

Hepion Pharmaceuticals, Inc.

$0.05 +18.52% $557.78K

Intercept Pharmaceuticals, Inc.

$19.00 +0.21% $794.69M

Inozyme Pharma, Inc.

$4.00 +0.25% $258.25M

Iovance Biotherapeutics, Inc.

$3.64 +5.20% $1.21B

Krystal Biotech, Inc.

$270.00 +0.97% $7.89B

Mereo BioPharma Group plc

$0.33 +2.81% $52.51M

Pliant Therapeutics, Inc.

$1.30 +0.38% $80.49M

PTC Therapeutics, Inc.

$73.01 +3.68% $6.04B

其他人也在看

Krystal Biotech, Inc.

PTC Therapeutics, Inc.

TG Therapeutics, Inc.

Terns Pharmaceuticals, Inc.

Viking Therapeutics, Inc.

Sarepta Therapeutics, Inc.

Day One Biopharmaceuticals, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言